Trial intelligence / Profile preview

Adjunctive Rosuvastatin in Renal Ablation

NCT01899027Phase 4Unknown

Sponsor
Sapienza University of Rome
Start
Jan 2014
Primary completion
Dec 2016
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of rosuvastatin in arterial hypertension (HTN), sponsored by Sapienza University of Rome. Status: unknown.

02

Drugs

rosuvastatin
03

Conditions

arterial hypertension (HTN)

Beyond the preview

Go deeper on NCT01899027.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01899027.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call